Meta-Analysis Reviews Opioid Use Disorder Treatments
A study of 95 trials evaluates the effectiveness of various substitution and antagonist therapies for opioid dependence.
Updated on Oct. 21, 2026 in Substance Abuse
Live Poll
Do you trust clinical research to guide your choices regarding opioid use disorder treatment?
Researchers recently published a meta-analysis assessing the benefits and harms of various pharmacological interventions for opioid use disorder. The study examined 95 randomized controlled trials involving a total of 26,624 participants.
Why it matters
The review helps clarify the comparative efficacy of common treatments in an effort to improve patient outcomes for opioid dependence. Identifying which therapies best support long-term retention remains a critical goal for global public health strategies.
The analysis included 26,624 participants with an average age of 36.25 years, of which 26% were female. While heroin-assisted therapy showed improved retention, no specific treatment demonstrated superiority over placebo for sustaining abstinence.
The details
The review integrated data from databases such as Medline and the Cochrane Library to evaluate 13 distinct pharmacological and control interventions. Findings indicated that high-dose methadone and heroin-assisted therapies improved treatment retention, though no clear differences were observed regarding mortality or overdose rates.
Timeline
The meta-analysis findings were published in October 2026.
Health Landscape
This study utilizes established meta-analysis protocols from the Cochrane Library to synthesize global data on opioid treatment efficacy. It builds upon existing medical frameworks to better understand how pharmacological interventions influence long-term recovery trajectories.
Patients and providers can use these findings to better understand the effectiveness of retention-focused therapies like high-dose methadone and buprenorphine. The study emphasizes that current treatment options are effective for retention but may require additional research to address sustained abstinence and mortality.
The takeaway
While several therapies show promise for keeping patients in treatment, the lack of superiority for maintaining abstinence suggests a need for diversified care strategies. Clinicians and patients should remain focused on evolving the drug supply context as a critical factor in treatment success.
Further reading
Learn more about the latest research and clinical standards in Substance Abuse.
Source note: This article includes information reported by Psychiatry Advisor.
Live Poll
Do you trust clinical research to guide your choices regarding opioid use disorder treatment?
